This document discusses tuberculosis screening criteria and testing. It provides a table outlining the criteria for a positive tuberculin skin test according to different risk groups. It also discusses causes of false negative and false positive skin test results. Finally, it introduces interferon-gamma release assays (IGRAs) as an alternative to the tuberculin skin test for detecting latent tuberculosis infection, noting their advantages in avoiding subjective interpretation but also their requirement for laboratory processing within 12 hours of blood draw.
This document discusses tuberculosis screening criteria and testing. It provides a table outlining the criteria for a positive tuberculin skin test according to different risk groups. It also discusses causes of false negative and false positive skin test results. Finally, it introduces interferon-gamma release assays (IGRAs) as an alternative to the tuberculin skin test for detecting latent tuberculosis infection, noting their advantages in avoiding subjective interpretation but also their requirement for laboratory processing within 12 hours of blood draw.
This document discusses tuberculosis screening criteria and testing. It provides a table outlining the criteria for a positive tuberculin skin test according to different risk groups. It also discusses causes of false negative and false positive skin test results. Finally, it introduces interferon-gamma release assays (IGRAs) as an alternative to the tuberculin skin test for detecting latent tuberculosis infection, noting their advantages in avoiding subjective interpretation but also their requirement for laboratory processing within 12 hours of blood draw.
Table 2. Criteria for a Positive Tuberculin Skin Test by Risk Group
Reaction ≥ 5 mm induration Reaction ≥ 10 mm induration (continued)
Fibrotic changes on chest radiography consistent with previous Persons with the following clinical conditions: tuberculosis Body weight 10 percent or more below the ideal Persons with human immunodeficiency virus infection Chronic renal failure and end-stage renal disease Persons with organ transplants, or who are otherwise Diabetes mellitus immunocompromised (including those who receive 15 mg or more Gastrectomy or intestinal bypass per day of prednisone or the equivalent for one month or longer, or Malignancy who receive other immunosuppressant medications) Silicosis Recent contacts of persons with active tuberculosis Residents and employees of the following high-risk Reaction ≥ 10 mm induration congregate living facilities: Children younger than four years or infants, children, and Prisons and jails adolescents exposed to high-risk adults Nursing homes for older patients or patients with High-risk racial and ethnic minorities, as defined locally acquired immunodeficiency syndrome Immigrants who have arrived within the past five years from Hospitals high-prevalence countries* Homeless shelters Persons who inject illicit drugs or use other locally identified Some medically underserved, low-income populations high-risk substances (e.g., crack cocaine) Mycobacteriology laboratory personnel Reaction ≥ 15 mm induration Persons with no risk factors for tuberculosis
*—All developing countries.
Adapted from Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimi- nation of Tuberculosis. MMWR Recomm Rep. 1995;44(RR-11):24, with additional information from references 12 and 14.
diagnostic standard, IGRAs are comparable
Table 3. Causes of False-Negative and False-Positive to TST in detecting LTBI.18 Tuberculin Skin Test Results The QuantiFeron-TB Gold test is the only IGRA that is approved by the U.S Food and Causes of false-negatives Causes of false-negatives Drug Administration and commercially Acquired immunodeficiency (continued) available in the United States. The CDC syndrome Systemic viral, bacterial, and released guidelines in 2005 stating that the Alcoholism fungal infections QuantiFeron-TB Gold test may be used Gastrectomy or intestinal bypass Use of corticosteroids or other immunosuppressant medications wherever TST is currently used.19 The test is Hematologic or lymphoreticular Zinc deficiency commercially available to tuberculosis con- disorders trol programs and institutions. Individual Inaccurate reading of induration Causes of false-positives physicians should consult their local labora- Live virus vaccines (measles, Boosting phenomenon† mumps, and rubella; poliovirus)* tory for availability and cost of the test. If it Cross-reaction with nontuberculous Malnutrition mycobacterial antigens is not available, TST should be continued. Patient age older than 45 years Error in administering the test IGRAs avoid the subjective nature of Renal failure Previous bacille Calmette-Guérin placing and interpreting TSTs and are less Sarcoidosis vaccination affected by previous BCG vaccinations.18,20 They also differentiate nontuberculosis *—When live virus vaccines are administered with the tuberculin skin test, the result reactions and obviate two-step tuberculin is not affected; if these vaccines are given before the tuberculin skin test, results may be false negatives for up to two months. testing associated with boosting effects.18,19 †—Institutions may use a two-step approach (test at baseline and again in one to three IGRAs are labor intensive, however, and weeks) to detect boosting reactors and avoid misclassifying them as converters. there is a 12-hour time limit from blood Information from references 16 and 17. draw to receipt in a qualified laboratory and incubation with the test antigens. Still, the
882 American Family Physician www.aafp.org/afp Volume 79, Number 10 ◆ May 15, 2009